CBT-161
Category:
ADCs
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
c-Met
Description:
CBT-161 is an ADC that STI-A0602, the monoclonal antibody targeting c-Met, links tubulin inhibitors or DNA damaging agents via C-lock. Preclinical study showed that CBT-161 significantly inhibited tumor growth.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
antitumor drug
MSDS:
Inquire
Application:
antitumor drug
Current Developer:
Sorrento Therapeutics
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items